Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed (Q39949338)

15 September 2017

Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed (English)

1 reference

15 September 2017

0 references

1 reference

Chris D Metcalfe

1

1 reference

15 September 2017

Shaogang Chu

2

1 reference

15 September 2017

Colin Judt

3

1 reference

15 September 2017

Hongxia Li

4

1 reference

15 September 2017

Ken D Oakes

5

1 reference

15 September 2017

Mark R Servos

6

1 reference

15 September 2017

David M Andrews

7

1 reference

15 September 2017

1 January 2010

1 reference

Environmental Toxicology and Chemistry

15 September 2017

1 reference

15 September 2017

29

1 reference

15 September 2017

1

1 reference

15 September 2017

79-89

1 reference

Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada

15 September 2017

1 reference

Solid-phase microextraction-gas chromatography-mass spectrometry for the analysis of selective serotonin reuptake inhibitors in environmental water

21 January 2018

1 reference

Bupropion in depression. II. The role of metabolites in clinical outcome

21 January 2018

1 reference

Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada

21 January 2018

1 reference

7 January 2021

Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during differing flow conditions

1 reference

7 January 2021

Human Pharmaceuticals in Wastewater Treatment Processes

1 reference

7 January 2021

A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States--II) untreated drinking water sources

1 reference

7 January 2021

Pharmaceuticals: a threat to drinking water?

1 reference

7 January 2021

Ozone treatment and the depletion of detectable pharmaceuticals and atrazine herbicide in drinking water sourced from the upper Detroit River, Ontario, Canada

1 reference

7 January 2021

Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway

1 reference

7 January 2021

Determination of antidepressants in surface and waste water samples by capillary electrophoresis with electrospray ionization mass spectrometric detection after preconcentration using off-line solid-phase extraction

1 reference

7 January 2021

Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS.

1 reference

7 January 2021

Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography-tandem mass spectrometry

1 reference

7 January 2021

Determination of select antidepressants in fish from an effluent-dominated stream.

1 reference

7 January 2021

Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode solid phase extraction cleanup and liquid chromatography-tandem mass spectrometry

1 reference

7 January 2021

Pharmacokinetics of selective serotonin reuptake inhibitors

1 reference

7 January 2021

Analysis of pharmaceuticals in water by isotope dilution liquid chromatography/tandem mass spectrometry.

1 reference

7 January 2021

Determination of pharmaceuticals in environmental waters by liquid chromatography/electrospray ionization/tandem mass spectrometry

1 reference

7 January 2021

Characterizing and compensating for matrix effects using atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry: analysis of neutral pharmaceuticals in municipal wastewater

1 reference

7 January 2021

Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria

1 reference

7 January 2021

Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man

1 reference

7 January 2021

Metabolism and excretion of citalopram in man: identification of O-acyl- and N-glucuronides

1 reference

7 January 2021

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

7 January 2021

A review of the metabolism and pharmacokinetics of paroxetine in man.

1 reference

7 January 2021

Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.

1 reference

7 January 2021

Care of depression in the elderly: comparative pharmacokinetics of SSRIs

1 reference

7 January 2021

The effects of pH on fluoxetine in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish.

1 reference

7 January 2021

Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes).

1 reference

7 January 2021

Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans

1 reference

7 January 2021

Mixture and single-substance acute toxicity of selective serotonin reuptake inhibitors in Ceriodaphnia dubia.

1 reference

7 January 2021

Effects of pharmaceuticals on Daphnia survival, growth, and reproduction

1 reference

7 January 2021

Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant

1 reference

7 January 2021

Identifiers

DOI

10.1002/ETC.27

1 reference

15 September 2017

1 reference